Cotreatment of HNSCC cells with EpEX led to a dose-dependent repression of EGF-mediated EMT, which was accompanied by reduction of ERK1/2 activation and Snail, Zeb1, and Slug transcription. The gene discussed is EGF; the disease is head and neck squamous cell carcinoma.